WaVe生命科學 WVE 深 滬
已收盤 10-31 16:00:00 美东时间
9.04
+0.740
+8.92%
華盛通- 最 高9.09
- 今 開8.29
- 成交量 524.69万股
- 最 低 8.175
- 昨 收 8.30
- 總市值 14.37亿
- 52周最高 16.735
- 市盈率 靜 --
- 換手率 3.30%
- 52周最低 5.28
- 委 比 -62.60%
- 總股本 1.59亿
- 歷史最高 56.00
- 量 比 0.91
- 振 幅 11.02%
- 歷史最低 1.16
- 每 手 1
- 風險率 2.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Wave Life Sciences announced promising results from its INLIGHT clinical trial of WVE-007, a GalNAc-siRNA for obesity treatment. The trial showed dose-dependent reductions of Activin E, up to 85%, with the lowest dose maintaining effects for six months, suggesting potential for annual dosing. WVE-007 was also found to be safe and well-tolerated. The company expects additional clinical data updates in late 2025 and throughout 2026. Additionally, W...
10-29 20:15
Wave Life Sciences Advances WVE-006 Study for AATD Treatment
Wave Life Sciences Pte. Ltd (($WVE)) announced an update on their ongoing clini...
10-28 05:53
Analysts’ Top Healthcare Picks: Climb Bio (CLYM), Wave Life Sciences (WVE)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
10-16 19:20
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Clear Street Initiates Coverage On WAVE Life Sciences with Buy Rating, Announces Price Target of $22
Clear Street analyst Bill Maughan initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $22.
10-15 18:49
Wave Life Sciences Highlights WVE-007 Obesity Treatment
The latest update is out from Wave Life Sciences ( ($WVE) ). On September 24, 2...
09-25 16:14
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
Wave Life Sciences Ltd. announces a virtual Research Day on October 29, 2025, and participation in upcoming investor conferences, including Bernstein's Healthcare Forum, Stifel's Cardiometabolic Forum, and Chardan's Genetic Medicines Conference. Details and live webcasts are available on their website. The company focuses on RNA medicines to treat various disorders and has a diversified pipeline in development.
09-18 12:30
Peering Into WAVE Life Sciences's Recent Short Interest
WAVE Life Sciences's (NYSE:WVE) short interest as a percent of float has risen ...
09-13 04:01
美股周涨跌榜 | 医药牛股频出！细胞动力周涨幅达50%，新药迎关键进展；美国联合医疗周涨超31%
医药牛股频出！细胞动力周涨幅达50%，新药迎关键进展；美国联合医疗周涨超31%，肺纤维化治疗取得重大突破；Lululemon周跌17%，此前下调年度利润及销售额预期>>
09-06 10:02
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
